Company profile: Genelex
1.1 - Company Overview
Company description
- Provider of pharmacogenetic testing for precision medication management, backed by innovative analytics software, state-of-the-art laboratory facilities, and expert staff; a pioneer in DNA testing since 1987.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Genelex
Genomic Health
HQ: United States
Website
- Description: Provider of genomic-based diagnostic tests addressing overtreatment and optimal treatment of early-stage cancer. Offers Oncotype DX Breast Recurrence Score for ER+/HER2- breast cancer, Riskguard Hereditary Cancer Test, OncoExTra genomic profiling for advanced/metastatic cancer, and developing colorectal screening (Next Generation Cologuard, blood test) and a Breast Radiation Score.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genomic Health company profile →
Organ-i
HQ: United States
Website
- Description: Provider of novel biotech diagnostic tests for renal diseases, improving clinicians’ ability to monitor the health of transplanted kidneys and providing valuable treatment information for patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Organ-i company profile →
Curetis
HQ: Germany
Website
- Description: Provider of molecular diagnostic tools for severe infectious diseases, offering the Unyvero Platform with multiplex PCR and broad panels for pathogen and resistance gene detection. Solutions include the integrated Unyvero System (L4 Lysator, C8 Cockpit, A50 Analyzer), application cartridges for syndromic testing, and the Unyvero A50 rapid solution delivering results in less than 5 hours.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Curetis company profile →
Seven Bridges
HQ: United States
Website
- Description: Provider of cloud-based infrastructure and data analytics for biomedical research, delivering the Seven Bridges Platform for storing, analyzing and interpreting bioinformatic data; BioInfoMiner for unsupervised genomic interpretation; RHEO for custom automation; GRAF for graph-based NGS variant calling; and ARIA for high-throughput molecular and health data cohort analysis at million-participant scale, with services and support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seven Bridges company profile →
Life Genomics
HQ: Sweden
Website
- Description: Provider of genetic testing services for healthcare and the public; founded in 2014 as a spin-off from TATAA Biocenter, operating a shared laboratory with TATAA, one of Europe’s premier, with backing including government ALMI Invest.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Life Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Genelex
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Genelex
2.2 - Growth funds investing in similar companies to Genelex
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Genelex
4.2 - Public trading comparable groups for Genelex
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →